Combining AZD8931, a novel EGFR/HER2/HER3 signalling inhibitor, with AZD5363 limits AKT inhibitor induced feedback and enhances antitumour efficacy in HER2-amplified breast cancer models

The phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signalling network is frequently de-regulated in breast cancer and has been shown to mediate resistance to anti-HER2 agents. Whilst constitutive activation of this pathway is emerging as a marker of sensitivity to vari...

Descripción completa

Detalles Bibliográficos
Autores principales: CRAFTER, CLAIRE, VINCENT, JOHN P., TANG, ERIC, DUDLEY, PHILLIPPA, JAMES, NEIL H., KLINOWSKA, TERESA, DAVIES, BARRY R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501645/
https://www.ncbi.nlm.nih.gov/pubmed/26095475
http://dx.doi.org/10.3892/ijo.2015.3062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501645/
https://www.ncbi.nlm.nih.gov/pubmed/26095475
http://dx.doi.org/10.3892/ijo.2015.3062

Ejemplares similares